Sheng-Li Xue, MD
Sheng-Li Xue, MD
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Venetoclax Combined With Azactidine in the Treatment of ALAL | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute biphenotypic leukemia, acute leukemia of ambiguous lineage, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2025-12-16 | NCT05901974 | |
| Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL | acute lymphoblastic leukemia | Recruiting | Phase 2 | 2025-11-21 | NCT05940961 |